Four months ago, a small pharmaceuticals company bought a medicine used to combat a rare growth disorder in children and quickly raised the list price by 150%.
Such a dramatic boost from $5,882 to $… [+975 chars]
An 'insane' calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates - statnews.com
A pharma company raised the price for a rare disease drug by 150%, arguing a new U.S. law left it no other choice.
By:Ed Silverman
Source:STAT
Published:
Related News
Doctors ignore new federal vaccine recommendations to stick with science - CNN
The American Academy of Pediatrics on Monday released its updated recommendations for what vaccines children should get. It’s a routine revision, hardly different from last year’s recommendations, but it carries more significance this year: More states and do…
CNN•Jen Christensen
This Is the Vaccine Story RFK Jr. Doesn’t Want You to Hear - The Bulwark
The Trump administration says we should learn from other countries. Maybe they should have looked someplace besides Denmark.
The Bulwark•Jonathan Cohn
Close to 90% of Americans have silent heart disease, AHA says - NewsNation
The AHA acknowledged that Cardiovascular-Kidney-Metabolic syndrome (CKM) is a condition that involves a chain reaction inside the body.
Newsnationnow.com•Rob Taub